Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiol Therapeutics (CRDL) Retained Earnings: 2021-2022

Historic Retained Earnings for Cardiol Therapeutics (CRDL) over the last 2 years, with Sep 2022 value amounting to -$82.0 million.

  • Cardiol Therapeutics' Retained Earnings fell 33.59% to -$82.0 million in Q3 2022 from the same period last year, while for Sep 2022 it was -$82.0 million, marking a year-over-year decrease of 33.59%. This contributed to the annual value of -$66.6 million for FY2021, which is N/A change from last year.
  • Per Cardiol Therapeutics' latest filing, its Retained Earnings stood at -$82.0 million for Q3 2022, which was down 5.63% from -$77.6 million recorded in Q2 2022.
  • Cardiol Therapeutics' Retained Earnings' 5-year high stood at -$54.8 million during Q2 2021, with a 5-year trough of -$82.0 million in Q3 2022.
  • Its 2-year average for Retained Earnings is -$69.2 million, with a median of -$69.6 million in 2021.
  • Data for Cardiol Therapeutics' Retained Earnings shows a maximum YoY tumbled of 41.66% (in 2022) over the last 5 years.
  • Cardiol Therapeutics' Retained Earnings (Quarterly) stood at -$66.3 million in 2021, then tumbled by 33.59% to -$82.0 million in 2022.
  • Its last three reported values are -$82.0 million in Q3 2022, -$77.6 million for Q2 2022, and -$73.0 million during Q1 2022.